PLSH
Panacea Life Sciences Holdings, Inc.
$0.07
+0.02 (+39.60%)
At close · Jul 2
Market Cap
$1.23M
Shares
17,645,352
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.07
Open$0.06
Day$0.06–0.07
52W$0.02–0.20
Avg vol 30d25K
Short int12K · 0.1% float · 1.0d
Short vol10%
DataApr 2022–Jul 2026
Filing10-Q · May 6
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+38% above
+
Price vs 50-day avg
+103% above
−
RSI (14)
85 · overbought
+
MACD trend
positive
◦
52-week position
27% · mid-range
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $0 › 200d $0 — 200d above 50d
◦
Institutional flow
0% holders QoQ
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.07% of float · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
1 holders — 13F breadth
Fundamentals
Strong
+
Revenue growth
+12% Y/Y
+
Gross margin
49%, expanding
+
EPS growth
+23% Y/Y
−
Free cash flow
$-1.6M
−
Balance sheet
net debt $726.4K
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2024
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+38% above
Bullish
Price vs 50-day avg
+103% above
Bullish
RSI (14)
85 · overbought
Bearish
MACD trend
positive
Bullish
52-week position
27% · mid-range
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.07% of float · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $0 · 27%
52-wk high $0
vs 200-day avg +38%
vs 50-day avg +103%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PLSH
this stock
Panacea Life Sciences Holdings, Inc.
|
$1.23M | +39.6% | +11.7% | — | 0.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$52.99B | +7.6% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$52.48B | +8.0% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.25B | -2.9% | — | — | 0.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
1
- % held
- 0.0%
- Net QoQ
- -735 sh
- Top holder
- Castleview Partners, LLC
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PLSH | +55.1% | +108.4% | +46.3% | +55.8% | +39.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +53.7% | +109.6% | +38.3% | +56.1% | +30.4% |